Immuno-Oncology Tops Embolization for Intermediate-Grade Liver Cancer

By News Health
10 hours Ago

(MedPage Today) — SAN FRANCISCO — An immuno-oncology (IO) regimen for intermediate-stage hepatocellular carcinoma (HCC) significantly extended treatment benefit versus transarterial chemoembolization (TACE), according to an interim analysis…

Source link : https://www.medpagetoday.com/meetingcoverage/mgics/119373

Author :

Publish date : 2026-01-10 20:15:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

What Do the New Dietary Guidelines Emphasize?

Global Pain Levels; Tertiary Patents on FDA-Approved Drugs

The True Miracle of Ivermectin

'The Pitt' Is Back for Another Harrowing 15-Hour Shift

Targeted Drug for Advanced Pancreatic Cancer Sparks Early Enthusiasm

What's the Best Diet for a Longer, Healthier Life?